Because SEC62 silencing inhibits cancer cell migration and increases sensitivity to Ca2+-driven cellular stress, we investigated whether Sec62 represents not only a possible new target for anti-cancer therapies, but also a prognostic marker for lung cancer patients. This evidence concerns the gene SEC62 and lung carcinoma.